MUKKA — Mukka Proteins Balance Sheet
0.000.00%
- IN₹8.36bn
- IN₹12.82bn
- IN₹10.06bn
- 26
- 55
- 16
- 20
Annual balance sheet for Mukka Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 125 | 180 | 405 | 944 | 223 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 734 | 715 | 1,409 | 2,302 | 2,000 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,565 | 2,864 | 4,640 | 8,165 | 9,257 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 816 | 813 | 834 | 835 | 944 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 3,539 | 3,923 | 5,752 | 9,408 | 10,763 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,671 | 2,764 | 4,028 | 5,209 | 6,110 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,883 | 2,939 | 4,274 | 5,447 | 6,356 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 657 | 984 | 1,478 | 3,961 | 4,407 |
Total Liabilities & Shareholders' Equity | 3,539 | 3,923 | 5,752 | 9,408 | 10,763 |
Total Common Shares Outstanding |